Variable | GEE analysisa | |||
---|---|---|---|---|
Adj. OR | 95% CI | P value | ||
Sex | ||||
Female (reference group) | - | - | - | - |
Male | 1.06 | 0.98 | 1.14 | 0.172 |
Age at diagnosis, years | ||||
≤44 (reference group) | - | - | - | - |
45–54 | 1.13 | 0.97 | 1.31 | 0.112 |
55–64 | 1.14 | 1.01 | 1.29 | 0.028* |
65–74 | 1.24 | 1.06 | 1.45 | 0.009* |
≥75 | 1.87 | 1.55 | 2.26 | <0.001* |
Urbanization level of residence location | ||||
Level 1 (highest; reference group) | - | - | - | - |
Level 2 | 0.97 | 0.86 | 1.08 | 0.555 |
Level 3 | 0.90 | 0.78 | 1.04 | 0.144 |
Level 4 | 0.89 | 0.76 | 1.05 | 0.172 |
Level 5 | 1.01 | 0.82 | 1.24 | 0.961 |
Level 6 | 1.01 | 0.82 | 1.23 | 0.961 |
Level 7 (lowest) | 0.96 | 0.76 | 1.22 | 0.761 |
Aboriginal status | ||||
No (reference group) | - | - | - | - |
Yes | 0.80 | 0.51 | 1.24 | 0.317 |
Insured monthly salary, NTD | ||||
≤17,280 (reference group) | - | - | - | - |
Insured dependent | 0.78 | 0.65 | 0.94 | 0.007* |
17,281–22,800 | 0.90 | 0.80 | 1.00 | 0.048* |
≥22,801 | 0.79 | 0.69 | 0.89 | <0.001* |
Low-income household status | ||||
No (reference group) | - | - | - | - |
Yes | 1.33 | 0.98 | 1.80 | 0.064 |
Other catastrophic illnesses or injuries | ||||
No (reference group) | - | - | - | - |
Yes | 1.66 | 1.37 | 2.02 | <0.001* |
Cancer stage | ||||
Stage 0 (reference group) | - | - | - | - |
Stage I | 0.38 | 0.29 | 0.48 | <0.001* |
Stage II | 0.29 | 0.22 | 0.39 | <0.001* |
Stage III | 0.35 | 0.27 | 0.47 | <0.001* |
Stage IV | 1.32 | 1.03 | 1.69 | 0.029* |
Charlson Comorbidity Index (CCI) | ||||
≤3 (reference group) | - | - | - | - |
4–6 | 1.29 | 1.07 | 1.56 | 0.009* |
≥7 | 1.28 | 1.05 | 1.56 | 0.013* |
Level of diagnosing hospital | ||||
Medical center (reference group) | - | - | - | - |
Regional hospital | 1.54 | 1.09 | 2.17 | 0.013* |
District hospital | 1.82 | 1.27 | 2.61 | 0.001* |
Ownership type of diagnosing hospital | ||||
Public (reference group) | - | - | - | - |
Private | 0.86 | 0.63 | 1.17 | 0.330 |